Search research articles
Contact Us
Filters
Showing results (101-110 of 499) with videos related to
Page
of 50
Sort By:
EMBO Reports
|
May 9, 2012
Losing balance: the origin and impact of aneuploidy in cancer
Andrew J Holland, Don W Cleveland
The New Biologist
|
November 1, 1989
Multiple determinants of eukaryotic mRNA stability
D W Cleveland, T J Yen
Nature Reviews. Neurology
|
December 17, 2016
Gene therapy: Gene-editing therapy for neurological disease
Moira A McMahon, Don W Cleveland
Proceedings of the National Academy of Sciences of the United States of America
|
February 21, 2014
Reply to Woodruff et al.: C1q and C3-dependent complement pathway activation does not contribute to disease in SOD1 mutant ALS mice
Christian S Lobsiger, Don W Cleveland
Nature Medicine
|
November 9, 2012
Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangements
Andrew J Holland, Don W Cleveland
Annual Review of Biochemistry
|
January 1, 1985
Molecular biology and genetics of tubulin
D W Cleveland, K F Sullivan
Experimental Neurology
|
August 27, 2014
Special Issue on amyotrophic lateral sclerosis
Bryan J Traynor, Don W Cleveland
Nature Neuroscience
|
April 9, 1999
Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons
T L Williamson, D W Cleveland
Genes & Development
|
October 1, 1992
Evidence for instability of mRNAs containing AUUUA motifs mediated through translation-dependent assembly of a > 20S degradation complex
S Savant-Bhonsale, D W Cleveland
Current Biology : CB
|
November 27, 1999
Cytoskeletal linkers: new MAPs for old destinations
M K Houseweart, D W Cleveland
Page
of 50
Search research articles
Search
Showing results (101-110 of 499) with videos related to
Sort By:
Page
of 50
EMBO Reports
|
May 9, 2012
Losing balance: the origin and impact of aneuploidy in cancer
Andrew J Holland, Don W Cleveland
The New Biologist
|
November 1, 1989
Multiple determinants of eukaryotic mRNA stability
D W Cleveland, T J Yen
Nature Reviews. Neurology
|
December 17, 2016
Gene therapy: Gene-editing therapy for neurological disease
Moira A McMahon, Don W Cleveland
Proceedings of the National Academy of Sciences of the United States of America
|
February 21, 2014
Reply to Woodruff et al.: C1q and C3-dependent complement pathway activation does not contribute to disease in SOD1 mutant ALS mice
Christian S Lobsiger, Don W Cleveland
Nature Medicine
|
November 9, 2012
Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangements
Andrew J Holland, Don W Cleveland
Annual Review of Biochemistry
|
January 1, 1985
Molecular biology and genetics of tubulin
D W Cleveland, K F Sullivan
Experimental Neurology
|
August 27, 2014
Special Issue on amyotrophic lateral sclerosis
Bryan J Traynor, Don W Cleveland
Nature Neuroscience
|
April 9, 1999
Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons
T L Williamson, D W Cleveland
Genes & Development
|
October 1, 1992
Evidence for instability of mRNAs containing AUUUA motifs mediated through translation-dependent assembly of a > 20S degradation complex
S Savant-Bhonsale, D W Cleveland
Current Biology : CB
|
November 27, 1999
Cytoskeletal linkers: new MAPs for old destinations
M K Houseweart, D W Cleveland
Page
of 50